Copper (II) and 2,2′-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Filho, Júlio César Conceição ^a   Sarria, André Lúcio Franceschini ^a   Becceneri, Amanda Blanque ^a   Fuzer, Angelina Maria ^a   Batalhão, Jaqueline Raquel ^a   Da Silva, Caio Marcio Paranhos ^a   Carlos, Rose Maria ^a   Vieira, Paulo Cezar ^a   Fernandes, João Batista ^a   Cominetti, Márcia Regina ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2,2' BIPYRIDINE; ANTINEOPLASTIC AGENT; CASPASE 9; COPPER(II) 2,2' BIPYRIDINE NARINGENIN COMPLEX; CUPRIC ION; GELATINASE B; NARINGENIN; UNCLASSIFIED DRUG; COORDINATION COMPOUND; COPPER; FLAVANONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CANCER PREVENTION; CASPASE 9 GENE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC50; ONCOGENE; PROTEIN EXPRESSION; UPREGULATION; ZYMOGRAPHY; BREAST NEOPLASMS; CHEMISTRY; CHEMOPROPHYLAXIS; DRUG EFFECTS; DRUG POTENTIATION; DRUG SCREENING; FEMALE; PATHOLOGY; TUMOR CELL LINE;

2,2'-DIPYRIDYL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOPREVENTION; COORDINATION COMPLEXES; COPPER; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; FEMALE; FLAVANONES; HUMANS;

EID: 84906996238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107058     Document Type: Article

References (68)

1. Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, et al. (2012) The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36: 237-248.
2. Stuckey A (2011) Breast Cancer: Epidemiology and Risk Factors. Clinical Obstetrics and Gynecology 54: 96-102.
3. WHO (2009) WHO projections of the global burden of disease including cancer: 2002-2030.
4. INCA (2007) Estimativas 2008: Incidência de Câncer no Brasil. Serviço de Divulgação Científica/Coordenação de Ensino e Divulgação Cientifica (CEDC) 1: 1-96.
5. Rivera E, Gomez H (2010) Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Res 12 Suppl 2: S2.
6. Prouse J (2010) The impact of methods of information on chemotherapy-related side effects. Clin J Oncol Nurs 14: 206-211.
7. Froidevaux-Klipfel L, Poirier F, Boursier C, Crepin R, Pous C, et al. (2011) Modulation of septin and molecular motor recruitment in the microtubule environment of the Taxol-resistant human breast cancer cell line MDA-MB- 231. Proteomics 11: 3877-3886.
8. Sims AH, Howell A, Howell SJ, Clarke RB (2007) Origins of breast cancer subtypes and therapeutic implications. Nat Clin Pract Oncol 4: 516-525.
9. Ivshina AV, George J, Senko O, Mow B, Putti TC, et al. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292-10301.
10. Demain AL, Vaishnav P (2010) Natural products for cancer chemotherapy. Microb Biotechnol 4: 687-699.
11. Chen AY, Chen YC (2013) A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem 138: 2099-2107.
12. Mishra PK, Raghuram GV, Bhargava A, Ahirwar A, Samarth R, et al. (2011) In vitro and in vivo evaluation of the anticarcinogenic and cancer chemopreventive potential of a flavonoid-rich fraction from a traditional Indian herb Selaginella bryopteris. Br J Nutr 106: 1154-1168.
13. Cibin TR, Devi DG, Abraham A (2010) Chemoprevention of skin cancer by the flavonoid fraction of Saraca asoka. Phytother Res 24: 666-672.
14. Nair HK, Rao KV, Aalinkeel R, Mahajan S, Chawda R, et al. (2004) Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol 11: 63-69.
15. Ramesh E, Alshatwi AA (2013) Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cells. Food Chem Toxicol 51: 97-105.
16. Harmon AW, Patel YM (2004) Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res Treat 85: 103-110.
17. Hatkevich T, Ramos J, Santos-Sanchez I, Patel YM (2014) A naringenintamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells. Exp Cell Res.
18. Lou C, Zhang F, Yang M, Zhao J, Zeng W, et al. (2012) Naringenin decreases invasiveness and metastasis by inhibiting TGF-beta-induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS One 7: e50956.
19. Qin L, Jin L, Lu L, Lu X, Zhang C, et al. (2011) Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell 2: 507-516.
20. Jin CY, Park C, Hwang HJ, Kim GY, Choi BT, et al. (2011) Naringenin upregulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells. Mol Nutr Food Res 55: 300-309.
21. Kerdudo A, Dingas A, Fernandez X, Faure C (2014) Encapsulation of rutin and naringenin in multilamellar vesicles for optimum antioxidant activity. Food Chem 159: 12-19.
22. Nishimura Fde C, de Almeida AC, Ratti BA, Ueda-Nakamura T, Nakamura CV, et al. (2013) Antioxidant effects of quercetin and naringenin are associated with impaired neutrophil microbicidal activity. Evid Based Complement Alternat Med 2013: 795916.
23. Cavia-Saiz M, Busto MD, Pilar-Izquierdo MC, Ortega N, Perez-Mateos M, et al. (2010) Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study. J Sci Food Agric 90: 1238-1244.
24. Jayaraman J, Veerappan M, Namasivayam N (2009) Potential beneficial effect of naringenin on lipid peroxidation and antioxidant status in rats with ethanolinduced hepatotoxicity. J Pharm Pharmacol 61: 1383-1390.
25. Jayaraman J, Jesudoss VA, Menon VP, Namasivayam N (2012) Antiinflammatory role of naringenin in rats with ethanol induced liver injury. Toxicol Mech Methods 22: 568-576.
26. Tsai SJ, Huang CS, Mong MC, Kam WY, Huang HY, et al. (2012) Antiinflammatory and antifibrotic effects of naringenin in diabetic mice. J Agric Food Chem 60: 514-521.
27. Goldwasser J, Cohen PY, Lin W, Kitsberg D, Balaguer P, et al. (2011) Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. J Hepatol 55: 963-971.
28. Paredes A, Alzuru M, Mendez J, Rodriguez-Ortega M (2003) Anti-Sindbis activity of flavanones hesperetin and naringenin. Biol Pharm Bull 26: 108-109.
29. Borst P, Rottenberg S, Jonkers J (2008) How do real tumors become resistant to cisplatin? Cell Cycle 7: 1353-1359.
30. Tan M, Zhu J, Pan Y, Chen Z, Liang H, et al. (2009) Synthesis, cytotoxic activity, and DNA binding properties of copper (II) complexes with hesperetin, naringenin, and apigenin. Bioinorg Chem Appl: 347872.
31. Baldini M, Belicchi-Ferrari M, Bisceglie F, Pelosi G, Pinelli S, et al. (2003) Cu(II) complexes with heterocyclic substituted thiosemicarbazones: the case of 5-formyluracil. Synthesis, characterization, x-ray structures, DNA interaction studies, and biological activity. Inorg Chem 42: 2049-2055.
32. Liu X, Zhang S, Ding Y (2012) Synthesis, crystal structures and reactivity of copper(I) amidate complexes with aryl halides: insight into copper(I)-catalyzed Goldberg reaction. Dalton Trans 41: 5897-5902.
33. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1: 2315-2319.
34. Almada da Silva J, Becceneri AB, Sanches Mutti H, Moreno Martin AC, Fernandes da Silva MF, et al. (2012) Purification and differential biological effects of ginger-derived substances on normal and tumor cell lines. J Chromatogr B Analyt Technol Biomed Life Sci 903: 157-162.
35. Sartiano GP, Lynch WE, Bullington WD (1979) Mechanism of action of the anthracycline anti-tumor antibiotics, doxorubicin, daunomycin and rubidazone: preferential inhibition of DNA polymerase alpha. J Antibiot (Tokyo) 32: 1038-1045.
36. Yue PY, Leung EP, Mak NK, Wong RN (2010) A simplified method for quantifying cell migration/wound healing in 96-well plates. J Biomol Screen 15: 427-433.
37. Selistre-de-Araujo HS, Cominetti MR, Terruggi CH, Mariano-Oliveira A, De Freitas MS, et al. (2005) Alternagin-C, a disintegrin-like protein from the venom of Bothrops alternatus, modulates alpha2beta1 integrin-mediated cell adhesion, migration and proliferation. Braz J Med Biol Res 38: 1505-1511.
38. Leber TM, Negus RP (2001) Detection and quantitation of matrix metalloproteases by zymography. Methods Mol Med 39: 509-514.
39. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
40. Shoemaker RH, Wolpert-DeFilippes MK, Kern DH, Lieber MM, Makuch RW, et al. (1985) Application of a human tumor colony-forming assay to new drug screening. Cancer Res 45: 2145-2153.
41. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66: 3034-3043.
42. Toth M, Sohail A, Fridman R (2012) Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Methods Mol Biol 878: 121-135.
43. Stark AM, Anuszkiewicz B, Mentlein R, Yoneda T, Mehdorn HM, et al. (2007) Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells. J Neurooncol 81: 39-48.
44. Barrett JM, Puglia MA, Singh G, Tozer RG (2002) Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells. Breast Cancer Res Treat 72: 227-232.
45. Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100.
46. Pontier SM, Muller WJ (2008) Integrins in breast cancer dormancy. APMIS 116: 677-684.
47. Bulzomi P, Bolli A, Galluzzo P, Acconcia F, Ascenzi P, et al. (2012) The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background. IUBMB Life 64: 690-696.
48. Lou CJ, Zhang FY, Yang M, Zhao J, Zeng WF, et al. (2012) Naringenin Decreases Invasiveness and Metastasis by Inhibiting TGF-beta-Induced Epithelial to Mesenchymal Transition in Pancreatic Cancer Cells. Plos One 7.
49. Arul D, Subramanian P (2013) Naringenin (Citrus Flavonone) Induces Growth Inhibition, Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinoma Cells. Pathol Oncol Res.
50. Arul D, Subramanian P (2013) Inhibitory effect of naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Biochem Biophys Res Commun 434: 203-209.
51. Iwashita K, Kobori M, Yamaki K, Tsushida T (2000) Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem 64: 1813-1820.
52. Duff B, Thangella VR, Creaven BS, Walsh M, Egan DA (2012) Anti-cancer activity and mutagenic potential of novel copper(II) quinolinone Schiff base complexes in hepatocarcinoma cells. Eur J Pharmacol 689: 45-55.
53. Puszko A, Brzuszkiewicz A, Jezierska J, Adach A, Wietrzyk J, et al. (2011) Systematic coordination chemistry and cytotoxicity of copper(II) complexes with methyl substituted 4-nitropyridine N-oxides. J Inorg Biochem 105: 1109-1114.
54. Rosu T, Pahontu E, Pasculescu S, Georgescu R, Stanica N, et al. (2010) Synthesis, characterization antibacterial and antiproliferative activity of novel Cu(II) and Pd(II) complexes with 2-hydroxy-8-R-tricyclo[7.3.1.0.(2,7)]tridecane- 13-one thiosemicarbazone. Eur J Med Chem 45: 1627-1634.
55. El Brahmi N, El Kazzouli S, Mignani SM, Essassi el M, Aubert G, et al. (2013) Original multivalent copper(II)-conjugated phosphorus dendrimers and corresponding mononuclear copper(II) complexes with antitumoral activities. Mol Pharm 10: 1459-1464.
56. Silva PP, Guerra W, Silveira JN, Ferreira AM, Bortolotto T, et al. (2011) Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage. Inorg Chem 50: 6414-6424.
57. Urquiola C, Gambino D, Cabrera M, Lavaggi ML, Cerecetto H, et al. (2008) New copper-based complexes with quinoxaline N1, N4-dioxide derivatives, potential antitumoral agents. J Inorg Biochem 102: 119-126.
58. Beckford FA, Thessing J, Stott A, Holder AA, Poluektov OG, et al. (2012) Anticancer activity and biophysical reactivity of copper complexes of 2- (benzo[d][1,3]dioxol-5-ylmethylene)-N-alkylhydrazinecarbothioamides. Inorg Chem Commun 15: 225-229.
59. Li TR, Yang ZY, Wang BD (2007) Synthesis, characterization and antioxidant activity of naringenin Schiff base and its Cu(II), Ni(II), Zn(II) complexes. Chem Pharm Bull (Tokyo) 55: 26-28.
60. Li YH, Wang BD, Yang ZY (2007) Infrared and DNA-binding on ultraviolet and fluorescence spectra of new copper and zinc complexes with a naringenin Schiff-base ligand. Spectrochim Acta A Mol Biomol Spectrosc 67: 395-401.
61. Vo V, Kabuloglu-Karayusuf ZG, Carper SW, Bennett BL, Evilia C (2010) Novel 4,4 '-diether-2,2 '-bipyridine cisplatin analogues are more effective than cisplatin at inducing apoptosis in cancer cell lines. Bioorganic & Medicinal Chemistry 18: 1163-1170.
62. Elwell KE, Hall C, Tharkar S, Giraud Y, Bennett B, et al. (2006) A fluorine containing bipyridine cisplatin analog is more effective than cisplatin at inducing apoptosis in cancer cell lines. Bioorganic & Medicinal Chemistry 14: 8692-8700.
63. Lee ER, Kang YJ, Kim HJ, Choi HY, Kang GH, et al. (2008) Regulation of apoptosis by modified naringenin derivatives in human colorectal carcinoma RKO cells. J Cell Biochem 104: 259-273.
64. Park JH, Jin CY, Lee BK, Kim GY, Choi YH, et al. (2008) Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol 46: 3684-3690.
65. Jin CY, Park C, Lee JH, Chung KT, Kwon TK, et al. (2009) Naringenininduced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells. Toxicol In Vitro 23: 259-265.
66. Arul D, Subramanian P (2013) Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res 19: 763-770.
67. Kekre N, Griffin C, McNulty J, Pandey S (2005) Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother Pharmacol 56: 29-38.
68. Kanno S, Tomizawa A, Ohtake T, Koiwai K, Ujibe M, et al. (2006) Naringenininduced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett 166: 131-139.